JP6289629B2 - 緑茶種子由来の２１−ｏ−アンゲロイルテアサポゲノールｅ３成分を含有する抗老化用皮膚外用剤組成物 - Google Patents
緑茶種子由来の２１−ｏ−アンゲロイルテアサポゲノールｅ３成分を含有する抗老化用皮膚外用剤組成物 Download PDFInfo
- Publication number
- JP6289629B2 JP6289629B2 JP2016525258A JP2016525258A JP6289629B2 JP 6289629 B2 JP6289629 B2 JP 6289629B2 JP 2016525258 A JP2016525258 A JP 2016525258A JP 2016525258 A JP2016525258 A JP 2016525258A JP 6289629 B2 JP6289629 B2 JP 6289629B2
- Authority
- JP
- Japan
- Prior art keywords
- angeloylteasapogenol
- green tea
- skin
- crude product
- precipitate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 35
- 244000269722 Thea sinensis Species 0.000 title description 36
- 235000009569 green tea Nutrition 0.000 title description 36
- 230000003712 anti-aging effect Effects 0.000 title description 7
- 238000002360 preparation method Methods 0.000 title description 6
- 230000037394 skin elasticity Effects 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 15
- 239000002537 cosmetic Substances 0.000 claims description 8
- 230000037303 wrinkles Effects 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 63
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 51
- 239000012043 crude product Substances 0.000 description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 38
- 239000000284 extract Substances 0.000 description 33
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 32
- 239000002244 precipitate Substances 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 22
- 239000000706 filtrate Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 21
- 102000004190 Enzymes Human genes 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 20
- 229940088598 enzyme Drugs 0.000 description 20
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 19
- 102000029816 Collagenase Human genes 0.000 description 18
- 108060005980 Collagenase Proteins 0.000 description 18
- 229960002424 collagenase Drugs 0.000 description 18
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 17
- 229930182490 saponin Natural products 0.000 description 17
- 150000007949 saponins Chemical class 0.000 description 17
- 102000016387 Pancreatic elastase Human genes 0.000 description 16
- 108010067372 Pancreatic elastase Proteins 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 239000000758 substrate Substances 0.000 description 16
- 238000010898 silica gel chromatography Methods 0.000 description 15
- 238000001914 filtration Methods 0.000 description 14
- 238000012360 testing method Methods 0.000 description 12
- 108010035532 Collagen Proteins 0.000 description 11
- 102000008186 Collagen Human genes 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- 229920001436 collagen Polymers 0.000 description 11
- 239000003960 organic solvent Substances 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 102000016942 Elastin Human genes 0.000 description 10
- 108010014258 Elastin Proteins 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 10
- 229920002549 elastin Polymers 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 244000005700 microbiome Species 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000004809 thin layer chromatography Methods 0.000 description 9
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 8
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 8
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 230000008030 elimination Effects 0.000 description 8
- 238000003379 elimination reaction Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 229960001295 tocopherol Drugs 0.000 description 8
- 229930003799 tocopherol Natural products 0.000 description 8
- 235000010384 tocopherol Nutrition 0.000 description 8
- 239000011732 tocopherol Substances 0.000 description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 239000012046 mixed solvent Substances 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000287 crude extract Substances 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 210000004177 elastic tissue Anatomy 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 108010001078 naringinase Proteins 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000036570 collagen biosynthesis Effects 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000012679 serum free medium Substances 0.000 description 3
- 229930185549 teaseedsaponin Natural products 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 108010059892 Cellulase Proteins 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 108010050808 Procollagen Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 108010030923 hesperidinase Proteins 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- VEVRNHHLCPGNDU-MUGJNUQGSA-N (2s)-2-amino-5-[1-[(5s)-5-amino-5-carboxypentyl]-3,5-bis[(3s)-3-amino-3-carboxypropyl]pyridin-1-ium-4-yl]pentanoate Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C([O-])=O)C(CC[C@H](N)C(O)=O)=C1 VEVRNHHLCPGNDU-MUGJNUQGSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 101001023866 Arabidopsis thaliana Mannosyl-oligosaccharide glucosidase GCS1 Proteins 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 241001467578 Microbacterium Species 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- 101000577106 Mus musculus Mannosyl-oligosaccharide glucosidase Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241000235402 Rhizomucor Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 240000005384 Rhizopus oryzae Species 0.000 description 1
- 235000013752 Rhizopus oryzae Nutrition 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 241000228341 Talaromyces Species 0.000 description 1
- 229930192129 Theasapogenol Natural products 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 210000001724 microfibril Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- -1 skins Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2013/006208 WO2015005511A1 (ko) | 2013-07-11 | 2013-07-11 | 녹차 종자 유래의 21-o-안젤로일데아사포젠올 e3 성분을 함유하는 항노화용 피부 외용제 조성물 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016528203A JP2016528203A (ja) | 2016-09-15 |
| JP6289629B2 true JP6289629B2 (ja) | 2018-03-07 |
Family
ID=52280179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016525258A Active JP6289629B2 (ja) | 2013-07-11 | 2013-07-11 | 緑茶種子由来の２１−ｏ−アンゲロイルテアサポゲノールｅ３成分を含有する抗老化用皮膚外用剤組成物 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP6289629B2 (zh) |
| CN (1) | CN105407895B (zh) |
| WO (1) | WO2015005511A1 (zh) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100755427B1 (ko) * | 2006-03-20 | 2007-09-04 | 주식회사 생그린 | 피부 탄력 증진 효과를 갖는 녹차씨 오일을 함유하는화장료 조성물. |
| KR101415995B1 (ko) * | 2008-09-08 | 2014-07-08 | (주)아모레퍼시픽 | 녹차 사포닌 21-ｏ-안젤로일티아사포제놀 ｅ3의 제조방법 |
| KR101694482B1 (ko) * | 2009-09-21 | 2017-01-10 | (주)아모레퍼시픽 | 녹차의 줄기세포를 함유하는 항산화 및 항노화용 화장료 조성물 |
| CN102160848A (zh) * | 2010-02-21 | 2011-08-24 | 候玉庆 | 一种祛斑贴片及其制备方法 |
| KR101263547B1 (ko) * | 2010-04-08 | 2013-05-13 | 인제대학교 산학협력단 | 녹차씨 껍질 추출물을 유효성분으로 함유하는 항산화 또는 항염 활성을 갖는 화장료 조성물 |
| US20120213845A1 (en) * | 2010-10-19 | 2012-08-23 | Bernstein Eric F | Skin composition comprising an exfoliate, a brightener and a collagen booster, and method of using the same |
| KR101272188B1 (ko) * | 2010-12-03 | 2013-06-07 | (주)바이오제닉스 | 칼콘계 화합물 함유 수계 가용화 조성물, 이를 이용한 미백 기능성 화장용 조성물 및 이들의 제조 방법 |
| KR101914157B1 (ko) * | 2011-08-24 | 2018-12-31 | (주)아모레퍼시픽 | 녹차 성분을 함유하는 화장료 조성물 |
| KR101824897B1 (ko) * | 2011-09-30 | 2018-02-05 | (주)아모레퍼시픽 | 차나무 뿌리 유래 사포닌을 함유하는 피부 외용제 조성물 |
| KR101865207B1 (ko) * | 2012-04-20 | 2018-06-08 | (주)아모레퍼시픽 | 녹차 종자 유래의 ２１-ｏ-안젤로일데아사포젠올 ｅ３ 성분을 함유하는 항노화용 피부 외용제 조성물 |
-
2013
- 2013-07-11 JP JP2016525258A patent/JP6289629B2/ja active Active
- 2013-07-11 WO PCT/KR2013/006208 patent/WO2015005511A1/ko active Application Filing
- 2013-07-11 CN CN201380078148.0A patent/CN105407895B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN105407895A (zh) | 2016-03-16 |
| JP2016528203A (ja) | 2016-09-15 |
| WO2015005511A1 (ko) | 2015-01-15 |
| CN105407895B (zh) | 2019-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5467106B2 (ja) | 緑豆発酵−酵素抽出液を含む皮膚老化防止用化粧料組成物 | |
| KR100727743B1 (ko) | 캄페롤을 유효성분으로 함유하는 피부 보습용, 피부 장벽기능 강화용, 및 피부 각질형성세포 분화 유도용 피부 외용 화장료 조성물 | |
| JP4939766B2 (ja) | 基底膜安定化剤 | |
| JP2010505441A (ja) | ケンペロール−３−ｏ−ルチノシドを製造する方法及びこれを含有する皮膚外用剤組成物 | |
| KR100757175B1 (ko) | 녹차 유래의 캄페롤을 유효성분으로 함유하는 주름 개선용 및 피부 탄력 향상용 피부 외용제 조성물 | |
| KR101885195B1 (ko) | 목서 발효추출물을 유효성분으로 함유하는 화장료 조성물 | |
| KR101737940B1 (ko) | 발효 콩잎 추출물을 유효성분으로 함유하는 피부 외용제 조성물 | |
| KR101865207B1 (ko) | 녹차 종자 유래의 ２１-ｏ-안젤로일데아사포젠올 ｅ３ 성분을 함유하는 항노화용 피부 외용제 조성물 | |
| KR101040508B1 (ko) | 녹두 발효-효소 추출액을 포함하는 피부 노화 방지 및 보습용 화장료 조성물 | |
| KR900004086B1 (ko) | 양모제 조성물 | |
| KR20170055172A (ko) | 중머리풀 추출물을 유효성분으로 함유하는 화장료 조성물 | |
| JP3280903B2 (ja) | 皮膚外用剤 | |
| KR20210060801A (ko) | 식물 복합 발효물을 유효성분으로 포함하는 항노화 화장료 조성물 | |
| JP6289629B2 (ja) | 緑茶種子由来の２１−ｏ−アンゲロイルテアサポゲノールｅ３成分を含有する抗老化用皮膚外用剤組成物 | |
| KR20200059446A (ko) | 새싹삼 잎, 줄기 발효액 또는 발효 추출액을 유효성분으로 하는 피부 주름개선용 화장료 조성물 및 그의 제조방법 | |
| JPH11158054A (ja) | 皮膚外用剤 | |
| KR20140143014A (ko) | 블랙커민（Ｎｉｇｅｌｌａ ｓａｔｉｖａ）추출물을 유효성분으로 포함하는 화장료 조성물 | |
| KR20140072419A (ko) | 주름 개선용 조성물 | |
| KR102062311B1 (ko) | 흰들버섯 추출물 제조방법, 이를 이용한 추출물 및 화장료 조성물 | |
| KR102528995B1 (ko) | 헥사펩타이드-11의 효모 발효물, 콜라겐의 가수분해물 및 4차 암모늄 화합물을 유효성분으로 포함하는 화장료 조성물 | |
| KR102525091B1 (ko) | 천연 복합 추출물을 유효성분으로 포함하는 모공 수축용 화장료 조성물 | |
| KR20190101067A (ko) | 닥나무 및 조 발효물을 유효성분으로 함유하는 화장품 조성물 및 그 제조방법 | |
| KR100892273B1 (ko) | 캄페롤-3-ｏ-루티노사이드를 유효 성분으로 함유하는 피부외용제 조성물 | |
| JP6255493B2 (ja) | 緑茶種子由来の２１−ｏ−アンゲロイルテアサポゲノールｅ３成分を含有する抗酸化又は皮膚美白用組成物 | |
| KR101442738B1 (ko) | 팥물 발효-효소 처리액을 유효성분으로 함유하는 주름 개선용 화장료 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160614 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170725 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170801 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20171030 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171228 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180116 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180206 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6289629 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |